Delivery Order SPE2DR25D7061-SPE2DR26F7XDR
Award Date 3/12/26
Potential Completion Date 3/13/26
Potential Value $4.7K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for $6,615.68 to supply Celebrex 100 mg capsule unit-dose packs (100 count) under firm fixed pricing, with an ultimate completion date of February 10, 2026. Place of performance is Conshohocken, PA. The order was issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply across...
- <p>The Defense Logistics Agency issued a $5,167.88 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Celebrex 100 mg capsule unit dose packages (100 count).</p> <p>This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. The order carries firm fixed pricing with no set-aside applied. Place of performance is Conshohocken, PA. Ultimate completion date is March 11, 2026.</p>
- The Defense Logistics Agency issued a $25,141.33 delivery order to AmerisourceBergen Drug Corp on February 11, 2026, for Celecoxib 100 mg tablets (100-count units). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) with a ceiling value of $1,557.18. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Celecoxib is a nonsteroidal anti-inflammatory drug commonly...
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp provides for the supply of Celebrex 200 mg capsules (100 count) with a ceiling value of $2,995.19 under a firm fixed price arrangement. The contract is not set aside and was competitively awarded by the Medical Supply Chain, a component of the Defense Logistics Agency. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for...
- This delivery order, valued at $8,663.41, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Celebrex 200 mg capsules in unit dose packaging (100 count). The contract was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, under its medical supply chain operations, is the funding federal agency, and performance...
- <p>The Defense Logistics Agency issued a $4,656.12 delivery order to Amerisourcebergen Drug Corp on February 16, 2026, for Celecoxib 100 mg tablets (100-count).</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price structure and no set-aside was used.</p>
- This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, is for one hundred fifty-five dollars worth of Celecoxib 100 mg capsules. The order is for one hundred capsules and is a firm fixed price contract with performance taking place in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. The completion date is September 12, 2023, approximately one year from the award date of September 11, 2023. As the Defense Logistics Agency is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) valued at $1,575.46. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,434 delivery order to Amerisourcebergen Drug Corporation for 200 mg Celebrex capsules. Under this firm fixed price contract, Amerisourcebergen will deliver 100 capsules to a location in Conshohocken, Pennsylvania by July 25, 2023. No major subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and ensures medical supplies like Celecoxib, the generic...
- SPE2DR25D7061Indefinite Delivery Contract
- SPE2DR25D7061-SPE2DR26F7XDRDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for Celebrex 200 mg capsule unit dose packages (100 count), with a ceiling value of $4,687.63. Place of performance is Conshohocken, PA. The ultimate completion date is March 13, 2026. This firm fixed-price delivery order was issued under no set-aside. The order calls for a branded anti-inflammatory pharmaceutical product for federal military and veteran healthcare systems.
Generated 6/10/26, 10:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 3/11/26 |